KrippendorfKH.Content Analysis: An Introduction to Its Methodology (3rd ed.). Sage: Thousand Oaks, CA, USA; 2012.
2.
BirnholtzJ, KrausA, SchnuerS, et al.“Oh, I don't really want to bother with that”: Gay and bisexual young men's perceptions of barriers to PrEP information and uptake. Cult Health Sex, 2021; 24(11):1548–1562; doi: 10.1080/13691058.2021.1975825.
3.
KrakowerD, BoulinA, DoughertyA, et al.Engaging adolescent sexual and gender minority persons in long-acting HIV Preexposure Prophylaxis in the U.S.: Lessons learned from HIV Prevention Trials Network Study 083-01. Rev Antiretrovir Ther Inf Dis, 2022; 6:90–91.
4.
Falconi-McCahillA, LeeAS, KnightsJE. Evaluation of a pre-exposure prophylaxis (PrEP) program for HIV prevention in a federally qualified health center (FQHC). Worldviews Evid Based Nurs, 2022; 19:219–226.
5.
GailloudL, Gonzalez-ArgotiT, PhilipS, et al.“How come they don't talk about it in school?” Identifying adolescent barriers to PrEP use. Health Educ Res, 2021; 36(5):505–517.
6.
RaoS, AlbrittonT, PinaP, et al.“You don't want your parents knowing that you're taking pre-exposure prophylaxis”: Pre-exposure prophylaxis stigma among black and latinx adolescents. J Assoc Nurses AIDS Care, 2022; 33(4):395–405.
7.
ShahSK, EssackZ, ByronK, et al.Adolescent barriers to HIV prevention research: Are parental consent requirements the biggest obstacle?. J Adolesc Health, 2020; 67:495–501.
8.
GasparM, WellsA, HullM, et al.“What other choices might I have made?”: Sexual minority men, the PrEP Cascade and the shifting subjective dimensions of HIV Risk. Qual Health Res, 2022; 32(8–9):1315–1327; doi: 10.1177/10497323221092701.
9.
BudhwaniH, YigitI, Maragh-BassAC, et al.Validation of HIV Pre-Exposure Prophylaxis (PrEP) medicatin scales with youth on PrEP: PrEP confidence scale and PrEP difficulties scale. AIDS Patient Care STDS, 2022; 36(11):443450; doi: 10.1089/apc.2022.0072.
10.
HongG, HorvathKJ, NelsonKM, et al.PrEP use and persistence among sexual minority men 17–24 years old during the COVID-19 pandemic. AIDS Behav, 2022; 26:631–638.
11.
PinaP, TaggartT, AcostaMS, et al.Provider comfort with prescribing HIV Pre-Exposure Prophylaxix to Adolescents. AIDS Patient Care STDs, 2021; 35:411–417; doi: 10.1089/apc.2021.0045.
12.
ArnoldT, Brinkley-RubinsteinL, ChanPA, et al.Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLoS One, 2017; 12(3):e0172354; doi: 10.1371/journal.pone.0172354.
